If you're on a drug for high blood pressure or heart failure, it's pretty likely that you're doing your best to keep your ...

Sacubitril/valsartan or Sac/Val was launched in the US in July 2015, under brand name Entresto and in five European markets ...

Even trace amounts of impurities in medication can spell trouble. Yet, recent research shows that nearly one-third of ...

Biocon has received approval for its generic drug to treat chronic heart failure. The medicine can be used both for adults ...

Biotechnology firm Biocon said its subsidiary has received approval from the US health regulator to market a generic ...

Medicare Part D provides coverage for Entresto. Learn more about Medicare drug coverage and the costs of Entresto.

Biocon's subsidiary, Biocon Pharma, has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Sacubitril/Valsartan tablets. This medication addresses ...

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure ...

HAE medications work to improve symptoms during an episode and prevent future episodes. Learn how IV administration and ...

The USFDA has also approved Biocon Limited subsidiary's ANDA for Daptomycin for Injection (500mg Vial) for skin infections.

Adam has resided at the intersection of legal and journalism for two decades. An award-winning journalist and legal strategist, he’s covered high-profile trials in Florida. After law school, Adam and ...

Biocon Chairperson Kiran Mazumdar-Shaw on Thursday called for more investment in research and development to drive innovation ...